• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2022 Feb 14;9(3):ofac027.
doi: 10.1093/ofid/ofac027. eCollection 2022 Mar.
Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults


Lacy M Simons[SUP] 1 2 [/SUP], Ramon Lorenzo-Redondo[SUP] 1 2 [/SUP], Meg Gibson[SUP] 3 [/SUP], Sarah L Kinch[SUP] 3 [/SUP], Jacob P Vandervaart[SUP] 4 [/SUP], Nina L Reiser[SUP] 5 6 [/SUP], Mesut Eren[SUP] 6 [/SUP], Elizabeth Lux[SUP] 6 [/SUP], Elizabeth M McNally[SUP] 5 6 7 [/SUP], Anat R Tambur[SUP] 3 [/SUP], Douglas E Vaughan[SUP] 6 [/SUP], Kelly E R Bachta[SUP] 1 [/SUP], Alexis R Demonbreun[SUP] 5 8 [/SUP], Karla J F Satchell[SUP] 5 9 [/SUP], Chad J Achenbach[SUP] 1 10 [/SUP], Egon A Ozer[SUP] 1 2 [/SUP], Michael G Ison[SUP] 1 3 [/SUP], Judd F Hultquist[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: While several demographic and clinical correlates of coronavirus disease 2019 (COVID-19) outcome have been identified, their relationship to virological and immunological parameters remains poorly defined.
Methods: To address this, we performed longitudinal collection of nasopharyngeal swabs and blood samples from a cohort of 58 hospitalized adults with COVID-19. Samples were assessed for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load, viral genotype, viral diversity, and antibody titer. Demographic and clinical information, including patient blood tests and several composite measures of disease severity, was extracted from electronic health records.
Results: Several factors, including male sex, higher age, higher body mass index, higher 4C Mortality score, and elevated lactate dehydrogenase levels, were associated with intensive care unit admission. Of all measured parameters, only the retrospectively calculated median Deterioration Index score was significantly associated with death. While quantitative polymerase chain reaction cycle threshold (Ct) values and genotype of SARS-CoV-2 were not significantly associated with outcome, Ct value did correlate positively with C-reactive protein levels and negatively with D-dimer, lymphocyte count, and antibody titer. Intrahost viral genetic diversity remained constant through the disease course and resulted in changes in viral genotype in some participants.
Conclusions: Ultimately, these results suggest that worse outcomes are driven by immune dysfunction rather than by viral load and that SARS-CoV-2 evolution in hospital settings is relatively constant over time.

Keywords: COVID-19; SARS-CoV-2; longitudinal cohort; viral evolution; viral load.
 
Back
Top Bottom